Huixin Bio

Huixin Bio is a developer of exosome purification products and early cancer detection technology.

ActiveBiopharmaBioTechPharmaceutical

Updated: Feb 17, 2026 ·

Recent News & Mentions

Huixin Bio has raised $14.4M across 1 funding round. Most recently, it raised $14.4M Series A in February 2026.

Total Raised

$14.4M

Valuation

N/A

Date	Round	Lead Investors	Other Investors
Feb 9, 2026	$14.4M Series A	Legend Capital

Huixin Bio has raised $14.4M across 1 funding round.

Total Raised

$14.4M

Valuation

N/A

How much funding has Huixin Bio raised?

Huixin Bio has raised $14.4M in total across 1 funding round.

Who are Huixin Bio's investors?

Huixin Bio's investors include Legend Capital.

How much funding has Huixin Bio raised?

Huixin Bio has raised $14.4M in total across 1 funding round.